Article info
Pharmacogenomics
Mendelian randomisation applied to drug development in cardiovascular disease: a review
- Correspondence to Dr Brent Richards, Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Côte Ste Catherine Road, Montreal, Quebec, Canada J3T 1E2; brent.richards{at}mcgill.ca
Citation
Mendelian randomisation applied to drug development in cardiovascular disease: a review
Publication history
- Received September 22, 2014
- Revised November 11, 2014
- Accepted November 12, 2014
- First published December 16, 2014.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions